Search Form
First, enter a politician or zip code
Now, choose a category

Key Votes

S 204 - Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 - National Key Vote

Peter DeFazio voted Nay (Passage) on this Legislation.

Read statements Peter DeFazio made in this general time period.

Timeline

Related Legislation

Issues Related to S 204

Stage Details

Legislation - Bill Passed (House) (250-169) - (Key vote)
See How Your Politicians Voted

Title: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017

Vote Result
Yea Votes
Nay Votes
Vote Smart's Synopsis:

Vote to pass a bill that authorizes terminally ill patients to use non FDA approved drugs after exhausting all other approved treatment options.

Highlights:
  • Authorizes patients with a diagnosed terminal illness be prescribed eligible investigational drugs for treatment options (Sec. 2).
  • Defines “eligible investigational drugs” as a drug that has completed phase 1 clinical trials but has not been approved or licensed under the Public Health Service Act (Sec. 2).

  • Requires that a physician immediately report to the drug manufacturer any serious adverse events associated with the use of the eligible investigational drug on a patient (Sec. 2).

Legislation - Introduced (Senate) -

Title: Trickett Wendler, Frank Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017

Sponsors

Co-sponsors

Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Thank You!

You are about to be redirected to a secure checkout page.

Please note:

The total order amount will read $0.01. This is a card processor fee. Please know that a recurring donation of the amount and frequency that you selected will be processed and initiated tomorrow. You may see a one-time charge of $0.01 on your statement.

Continue to secure page »

Back to top